The epidemiological effect and cost-effectiveness of expanded age eligibility for recombinant zoster vaccination in England

Ku C-C., Rosello A., Walker J., Pouwels KB., Baguelin M., Davies NG., Jit M.

DOI

10.1016/j.vaccine.2026.128405

Type

Journal article

Publisher

Elsevier BV

Publication Date

2026-04-01T00:00:00+00:00

Volume

78

Pages

128405 - 128405

Total pages

0

Permalink More information Close